UroGen Pharma has filed a notice of an exempt offering of securities to raise $120 Million in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, UroGen Pharma is raising $120,000,000.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Don Kim played a key role…